Childhood cancer: occurrence, treatment and risk of second primary malignancies

S Zahnreich, H Schmidberger - Cancers, 2021 - mdpi.com
Simple Summary Childhood cancers are mostly of unknown etiology and represent
devastating diagnoses. The clinical benefits of steadily increasing tumor control and survival …

Natural compounds as promising adjuvant agents in the treatment of gliomas

F Persano, G Gigli, S Leporatti - International Journal of Molecular …, 2022 - mdpi.com
In humans, glioblastoma is the most prevalent primary malignant brain tumor. Usually,
glioblastoma has specific characteristics, such as aggressive cell proliferation and rapid …

Genomic classification and clinical outcome in rhabdomyosarcoma: a report from an international consortium

JF Shern, J Selfe, E Izquierdo, R Patidar… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE Rhabdomyosarcoma is the most common soft tissue sarcoma of childhood.
Despite aggressive therapy, the 5-year survival rate for patients with metastatic or recurrent …

Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcoma

J DeMartino, MT Meister, LL Visser, M Brok… - Nature …, 2023 - nature.com
Paediatric rhabdomyosarcoma (RMS) is a soft tissue malignancy of mesenchymal origin that
is thought to arise as a consequence of derailed myogenic differentiation. Despite intensive …

Triggered release from thermosensitive liposomes improves tumor targeting of vinorelbine

M Regenold, K Kaneko, X Wang, HB Peng… - Journal of Controlled …, 2023 - Elsevier
Triggered drug delivery strategies have been shown to enhance drug accumulation at target
diseased sites in comparison to administration of free drug. In particular, many studies have …

Relapsed rhabdomyosarcoma

CM Heske, L Mascarenhas - Journal of clinical medicine, 2021 - mdpi.com
Relapsed rhabdomyosarcoma (RMS) represents a significant therapeutic challenge. Nearly
one-third of patients diagnosed with localized RMS and over two-thirds of patients with …

[HTML][HTML] International society of paediatric surgical oncology (IPSO) surgical practice guidelines

SCV Abib, CH Chui, S Cox, AH Abdelhafeez… - …, 2022 - ncbi.nlm.nih.gov
Most children with tumors will require one or more surgical interventions as part of the care
and treatment, including making a diagnosis, obtaining adequate venous access …

Recent advances and challenges in the treatment of rhabdomyosarcoma

S Miwa, N Yamamoto, K Hayashi, A Takeuchi… - Cancers, 2020 - mdpi.com
Rhabdomyosarcoma, the most common soft tissue sarcoma noted in childhood, requires
multimodality treatment, including chemotherapy, surgical resection, and/or radiation …

[HTML][HTML] Enhanced drug release from a pH-responsive nanocarrier can augment colon cancer treatment by blocking PD-L1 checkpoint and consuming tumor glucose

K Guo, Y Liu, M Ding, Q Sun, QTH Shubhra - Materials & Design, 2022 - Elsevier
In this study, it was aimed to exploit no chemical drug to treat cancer by starvation-
immunotherapy combination. We used PD-L1 siRNA to down-regulate checkpoint protein …

DNMT3A and DNMT3B targeting as an effective radiosensitizing strategy in embryonal rhabdomyosarcoma

S Camero, G Vitali, P Pontecorvi, S Ceccarelli… - Cells, 2021 - mdpi.com
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in childhood. Recently,
we demonstrated the overexpression of both DNA methyltransferase 3A (DNMT3A) and 3B …